BL
Biocon Ltd
Manufacturer · Bengaluru, India
GMP
Overview
Biocon is a Bengaluru biopharmaceutical company incorporated in 1978 and listed in India since 2004, working in generics, biosimilars and research services. It received US FDA approval in February 2026 for a generic liraglutide pen and describes a vertically integrated development and manufacturing platform for GLP-1 products. It holds active US Type II DMFs for Liraglutide, Semaglutide, Tirzepatide. FDA inspected its Bengaluru API facility (Site 2) in September 2024.
Capabilities
- Peptide APIs (GLP-1)
- Complex injectable formulations
- Biosimilars
- Generic APIs
Quality signals
| GMP evidence | Yes |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |